BGI Genomics and Colombian National Cancer Institute Collaborate to enhance cancer detection and prevention

On October 2, 2023, BGI Genomics signed a Memorandum of Understanding (MoU) with the Colombian National Cancer Institute (INC or Instituto Nacional de Cancerologia).

Overboard: Alexis Borisy will have to limit director posts to stay on at Blueprint

Repeat biotech founder Alexis Borisy will have to give up at least two of his public board seats within a year, since the investor is

June 29, 2023

Researchers validate first-ever AI biomarker for ADT benefit in prostate cancer

Data from a new study published in NEJM Evidence shows promise for personalized use of short-term ADT in men with predominantly intermediate-risk prostate cancer.

June 30, 2023

Stopping illicit steroids associated with depression and sexual dysfunction in men

Men who illicitly used steroids to boost muscle size and physical performance and have stopped in the past year have impaired sexual function compared with

June 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.